I haven't given FFP or platelets in forever. Specializes in ICU. Specializes in Oncology, LTC. Usually we just dump it in, unless they have CHF or fluid overload, then it's a slow drip with frequent monitoring. Like an earlier post stated, if the patient needs platelets, they need them ASAP. Specializes in adult ICU. Platelets are higher risk for transfusion reaction than other types of blood products for the reason stated above.
I think it is unlikely that the reaction you speak of had to do with the fact that you ran the platelets in quickly as that is the standard of care at most institutions to my knowledge. Patient should go through a transfusion workup like any other reaction so the blood bank can make recommendations for future transfusions. Edited Aug 19, by grandmawrinkle. Specializes in Oncology. Has 15 years experience. Rebulla P. Revisitation of the clinical indications for the transfusion of platelet concentrates.
Rev Clin Exp Hematol. Platelet transfusion trigger in difficult patients. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
Br J Hematol. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit Rev Oncol Hematol. Do basic laboratory tests or clinical observation predict bleeding in thrombocytopenic oncology patients? Biol Blood Marrow Transplant. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. Heal MH, Blumberg N. Optimizing platelet transfusion therapy.
Blood Reviews. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. The risk of bleeding in thrombocytopenic patients with acute myeloid leukaemia.
British Committee for Standards in Hematology General Haematology Task Force Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Platelet immunopathology and therapy: a Canadian Blood Services research and development symposium.
Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Clinical impact of neonatal thrombocytopenia. J Pediatr. A randomised, controlled trial of platelet transfusions in thrombocytopenic premature infants.
Platelet transfusion therapy in newborn infants. Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Uraemic bleeding: role of anemia and beneficial effect of red cell transfusions. Contribution of the haematocrit to the bleeding time. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions.
Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients.
Burns ER, Lawrence C. Bleeding time. A guide to its diagnostic and clinical utility. Ho CH. The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia.
The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss.
Eugster M, Reinhart WH. The influence of the hematocrit on primary haemostasis in vitro. Thromb Haemost. Insights into the risk of bleeding in thrombocytopenic patients with acute leukaemia [abstract] Transfusion.
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Lozano M, Cid J. Apheresis platelet transfusion: does ABO matter? Platelet transfusion therapy. One hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.
The value of minute post-transfusion platelet counts. Factors influencing hour increments after platelet transfusion.
Diagnosis and treatment of patients refractory to platelet transfusions. Novotny VM. Prevention and management of platelet transfusion refractoriness.
The management of heparin-induced thrombocytopenia. British Committee for Standards in Haematology Guidelines on the use of leucocyte-depleted blood components. Evidence-based recommendations for the use of WBC-reduced cellular blood components. The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.
British Committee for Standards in Haematology Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host-disease. Appendix A. Appendix B. Support Center Support Center. External link. Please review our privacy policy. Apheretic treatment of thrombotic microangiopathies thrombotic thrombocytopenic purpura, haemolytic-uraemic syndrome, HELLP syndrome , as a replacement fluid.
Reconstitution of whole blood for exchange transfusions. Hereditary angioedema in the case that C1-esterase inhibitor is not available. AL, except acute promyelocytic leukaemia FAB M3 , in unstable patients 4 , 10 , 15 , 17 , 19 — 22 , 27 , 35 , AL, during a clinically stable period, except acute promyelocytic leukaemia FAB M3 4 , 10 , 15 , 17 , 19 — 22 , 27 , 35 , Acute promyelocytic leukaemia FAB M3 4 , 10 , 15 , 17 , 19 — 22 , 27 , Bone marrow aplasia and myelodysplasias, in unstable patients or during active treatment 8 , Bone marrow aplasia and myelodysplasias in stable patients 8 , Allogeneic bone marrow transplantation 4 , 10 , 15 , 17 , 19 — 22 , 27 , Autologous peripheral blood stem cell transplantation Bladder cancers or necrotic tumours, during active and aggressive treatment 8 , Solid tumours, during active treatment 8 , Ocular surgery or neurosurgery 4 , 8 , 10 , 18 , 28 — Major surgery, with other risk factors 4 , 8 , 10 , 18 , 28 — Major surgery, in non-critical sites 4 , 8 , 10 , 18 , 28 — Lumbar puncture, epidural anaesthesia, endoscopy with biopsy, placement of a CVC, liver biopsy 4 , 8 , 10 , 18 , 28 — Outpatient transfusions may be stopped.
Platelet transfusions may be limited to only patients with life-threatening bleeding if necessary, to preserve a limited platelet inventory. References Kaufman RM et al. Sign in here. We have placed cookies on your device to help make this website better. You can adjust your cookie settings , otherwise we'll assume you're okay to continue. How fast can a bag of platelets be infused? Share More sharing options Followers 0.
Recommended Posts. Posted July 28, Link to comment Share on other sites More sharing options L Posted July 28,
0コメント